Form D Explorer
Cellphire, Inc. · CIK 1815181

Report a data issueCitable research briefCompare issuerPrivate research collection

Cellphire, Inc.

CIK 1815181 · Corporation · Inc. DELAWARE · ROCKVILLE, Maryland · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Dec 11, 2025
through Nov 16, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldDec 11, 2025 · DNov 16, 2026 · DLater minus earlier
Reported offering amount$3,000,000$8,000,000$5,000,000
Reported amount sold$3,000,000$6,494,308$3,494,308
Reported investor count—22—
Reported minimum investment$17,736$1,000$-16,736

Earlier SEC source: 0001815181-25-000002 · Later SEC source: 0001815181-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Nov 16, 2026

Reported offering amount
$8,000,000
Reported exemptions
Rule 506(c)
Reported amount sold
$6,494,308

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)